Drug · DIN 02339366
PRECEDEX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 13, 2025; first marketed February 24, 2010.
- Drug Identification Number (DIN)
- 02339366
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Dexmedetomidine N05CM18
- Class
- Human
- Record last updated
- December 16, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) | 100 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 7, 2018: NOC 20588New Drug Submission (NDS) · Merger - buyout
- December 9, 2009: NOC 10853New Drug Submission (NDS)
Other DINs named PRECEDEX
- DIN 02437147 · Marketed